Valiant Organics has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ending March 31, 2026, to the Bombay Stock Exchange and National Stock Exchange. The filing details the company’s environmental, social, and governance performance alongside operational metrics.

The company reported a turnover of ₹738.38 crore and a net worth of ₹696.85 crore for FY26. These figures trigger compliance with Section 135 of the Companies Act, 2013, making Corporate Social Responsibility (CSR) spending mandatory.

Operational and Environmental Metrics

The specialty chemicals manufacturer operates six plants and one office across India. Its product portfolio is dominated by dyes and pigments, which contributed 45% of total turnover. Agro-chemicals accounted for 24%, while pharmaceuticals represented 21%.

Exports constituted approximately 5% of total turnover during the period. The company serves customers in 29 Indian states and four international countries.

Energy and Waste Management

Total energy consumption rose to 2,161.42 Terajoules from 1,905.64 Terajoules in FY25. Non-renewable sources accounted for the vast majority of this usage at 2,140.88 Terajoules. Renewable energy consumption stood at 20.54 Terajoules.

Greenhouse gas emissions increased year-on-year. Scope 1 emissions reached 150,072.61 metric tonnes of CO2 equivalent, up from 132,555.19 metric tonnes. Scope 2 emissions totaled 29,077.66 metric tonnes. Total waste generated jumped to 34,999.75 metric tonnes, compared to 26,160.74 metric tonnes in the prior year.

Workforce and Safety

The company employed 670 permanent employees and engaged 239 workers at the end of FY26. Female representation among employees remained low at 1.79%. The turnover rate for permanent employees was 23.65%, slightly higher than the 21.36% recorded in FY25.

Safety incidents included one work-related fatality among workers. The Lost Time Injury Frequency Rate (LTIFR) for employees was zero, while it stood at 0.37 for workers. The company maintains ISO 45001:2018 certification for its Occupational Health and Safety Management System across all manufacturing facilities.

What the Numbers Show

A significant concentration risk exists in related-party transactions. Related parties accounted for 64.59% of total purchases and 42.85% of total sales. Furthermore, 100% of the company’s investments were directed toward related parties, indicating heavy reliance on its corporate group for capital deployment and supply chain stability.

Valiant Organics reported a consolidated net profit of ₹293 crore for the quarter ended June 30, 2026, marking a 257% increase from ₹82 crore in the same period last year. Operational revenue rose 13.3% year-on-year to ₹2,315 crore, reflecting improved demand across its specialty chemicals portfolio.

The company’s earnings presentation, filed with stock exchanges on August 21, 2026, highlights significant margin expansion. Consolidated EBITDA grew 67.7% to ₹416 crore, pushing the operating margin to 17.97%, the highest in six quarters. This improvement was supported by a reduction in raw material costs, which fell to 57% of sales from 61% previously.

Financial Performance

The bottom-line improvement was broad-based, driven by operational efficiency and lower finance costs. Key financial metrics for Q1FY27 are outlined below:

Standalone net profit also surged, rising 187% to ₹218 crore from ₹76 crore in Q1FY26. Standalone revenue remained flat at ₹2,315 crore, indicating that the parent entity accounts for the majority of the group's operational turnover.

What the Numbers Show

A significant portion of the profit growth stems from non-operational sources. The share of profit from associates contributed ₹72 crore to the consolidated PBT, compared to just ₹6 crore in Q1FY26. While operational EBITDA drove margin expansion, this surge in associate profits indicates a high dependency on joint ventures or equity investments for the current quarter’s bottom-line beat. Additionally, gross profit margins improved to 43% from 39%, aided by a ~410 basis point reduction in raw material consumption.

Segmental Highlights

Hydrogenation remains the largest revenue contributor, accounting for 54% of total sales in Q1FY27. Revenue from this segment grew to ₹1,272 crore from ₹1,082 crore year-ago. Chlorination revenue also expanded to ₹451 crore, up from ₹394 crore. Ammonolysis revenue remained stable at ₹478 crore.

Volume data reveals mixed trends. Chlorination sales volumes declined to 2,623 MT from 3,301 MT, suggesting price-led revenue growth. Conversely, hydrogenation volumes saw a slight dip to 4,916 MT from 5,491 MT in Q4FY26 but remain robust compared to prior periods.

Balance Sheet and Outlook

The company maintains a conservative leverage profile. As of FY26, the net debt-to-equity ratio stood at 0.33x, unchanged from FY25. Total borrowings were ₹2,527 crore (consolidated), comprising ₹526 crore in non-current liabilities and ₹2,001 crore in current liabilities. Cash and cash equivalents were minimal at ₹18 crore.

Management noted that employee and other expenses increased only 4.6% despite 14% revenue growth, reflecting improved operating efficiency. Finance costs declined 15% to ₹51 crore. The company operates six manufacturing units across five locations with a total capacity of 70,000 tonnes per annum.